The Impact of the COVID-19 Pandemic on Tobacco Treatment Program Implementation at NCI-Designated Cancer Centers.
Sarah D HohlKimberly Ann ShoenbillKathryn L TaylorMara MinionGleneara E Bates-PappasRashelle B HayesMargaret B NolanVani N SimmonsMichael B SteinbergElyse R ParkKimlin AshingDiane BeneventiLisa Sanderson CoxAdam O GoldsteinAndrea KingChris KotsenCary A PresantScott E ShermanChristine E ShefferGraham W WarrenRobert T AdsitJennifer E BirdHeather D'AngeloMichael C FioreClaire Van Thanh NguyenDanielle PaukBetsy RollandNancy A RigottiPublished in: Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco (2022)
This work describes how NCI-designated cancer centers participating in the Cancer Center Cessation Initiative (C3I) adapted to challenges to sustain evidence-based tobacco use treatment programs during the COVID-19 pandemic. This work offers a model for resilience and rapid transition to remote tobacco treatment services delivery and proposes a policy and research agenda for telehealth services as an approach to sustaining evidence-based tobacco treatment programs.